Pier Giuseppe Pelicci
Researcher Next ID · RN-035088
Researcher · Biochemistry, Genetics and Molecular Biology
Milan, Italy
- Works count
- 951
- Citation count
- 65,470
- H-index
- 127
- i10-index
- 481
Research interests
Publications
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
Cancer Cell · 2019 · https://doi.org/10.1016/j.ccell.2019.03.007
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Nature reviews. Cancer · 2017 · https://doi.org/10.1038/nrc.2016.140
Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth
Science · 2017 · https://doi.org/10.1126/science.aag2553
BLUEPRINT to decode the epigenetic signature written in blood
Nature Biotechnology · 2012 · https://doi.org/10.1038/nbt.2153
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
Cell · 2010 · 10.1016/j.cell.2009.12.007
Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66 shc Gene
Circulation Research · 2006 · https://doi.org/10.1161/01.res.0000231289.63468.08
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Nature · 2006 · https://doi.org/10.1038/nature05327
Human Chromosome 7: DNA Sequence and Biology
Science · 2003 · https://doi.org/10.1126/science.1083423
The tripartite motif family identifies cell compartments
The EMBO Journal · 2001 · https://doi.org/10.1093/emboj/20.9.2140
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Nature · 2000 · 10.1038/35018127
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
PubMed · 1999 · https://doi.org/10.1182/blood.v94.10.3509.422k36_3509_3515
ALK+ lymphoma: clinico-pathological findings and outcome.
PubMed · 1999 · https://doi.org/10.1182/blood.v93.8.2697
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Nature · 1999 · 10.1038/46311
ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
American Journal Of Pathology · 1998 · https://doi.org/10.1016/s0002-9440(10)65629-5
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
PubMed · 1997 · https://doi.org/10.1182/blood.v90.3.1014
Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein
Blood · 1993 · https://doi.org/10.1182/blood.v82.5.1573.1573
Current projects
No projects listed.